Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Peroxidation processes, cytokines, BALF and blood cytology in patients with occupational lung diseases and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 275s Year: 2002
Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007
Phenotypic analysis of lymphocytes in bronchoalveolar lavage fluid and peripheral blood from patients with chronic inflammatory lung diseases Source: Eur Respir J 2004; 24: Suppl. 48, 534s Year: 2004
Phenotypic analysis of BAL lympocytes and respiratory function in chronic inflammatory lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 543s Year: 2005
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid Source: Eur Respir J 2004; 24: 964-970 Year: 2004
Comparative proteomics of human bronchoalveolar lavage fluid from COPD and non-COPD subjects Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008
Role of BALF in differential diagnosis of smoking related interstitial lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Predictive variables to obtain a bronchoalveolar lavage of adequate quality in patients with interstitial lung diseases Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019
Antimicrobial peptides in bronchoalveolar lavage in patients with chronic lung diseases Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018
Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021
Altered microRNA profiles in the bronchoalveolar lavage fluid exosomes in asthma and COPD Source: International Congress 2016 – Extracellular vesicles in lung disease pathogenesis Year: 2016
Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Comparison of cellular composition of induced sputum, bronchial washing and bronchoalveolar lavage fluid in some interstitial lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002